1. Home
  2. NRSN vs MOGO Comparison

NRSN vs MOGO Comparison

Compare NRSN & MOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • MOGO
  • Stock Information
  • Founded
  • NRSN 2017
  • MOGO 2003
  • Country
  • NRSN Israel
  • MOGO Canada
  • Employees
  • NRSN N/A
  • MOGO N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • MOGO
  • Sector
  • NRSN Health Care
  • MOGO
  • Exchange
  • NRSN Nasdaq
  • MOGO Nasdaq
  • Market Cap
  • NRSN 26.3M
  • MOGO 24.5M
  • IPO Year
  • NRSN 2021
  • MOGO N/A
  • Fundamental
  • Price
  • NRSN $1.31
  • MOGO $1.34
  • Analyst Decision
  • NRSN
  • MOGO Strong Buy
  • Analyst Count
  • NRSN 0
  • MOGO 1
  • Target Price
  • NRSN N/A
  • MOGO $6.00
  • AVG Volume (30 Days)
  • NRSN 181.1K
  • MOGO 143.7K
  • Earning Date
  • NRSN 11-26-2024
  • MOGO 11-06-2024
  • Dividend Yield
  • NRSN N/A
  • MOGO N/A
  • EPS Growth
  • NRSN N/A
  • MOGO N/A
  • EPS
  • NRSN N/A
  • MOGO N/A
  • Revenue
  • NRSN N/A
  • MOGO $30,995,226.00
  • Revenue This Year
  • NRSN N/A
  • MOGO N/A
  • Revenue Next Year
  • NRSN N/A
  • MOGO $12.48
  • P/E Ratio
  • NRSN N/A
  • MOGO N/A
  • Revenue Growth
  • NRSN N/A
  • MOGO N/A
  • 52 Week Low
  • NRSN $0.47
  • MOGO $0.94
  • 52 Week High
  • NRSN $2.33
  • MOGO $2.25
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 61.44
  • MOGO 60.95
  • Support Level
  • NRSN $1.23
  • MOGO $0.95
  • Resistance Level
  • NRSN $1.34
  • MOGO $1.95
  • Average True Range (ATR)
  • NRSN 0.10
  • MOGO 0.13
  • MACD
  • NRSN 0.01
  • MOGO 0.05
  • Stochastic Oscillator
  • NRSN 75.00
  • MOGO 39.60

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.

Share on Social Networks: